datalabs-logo

  • Ask Datalabs
  • My Feed
  • Companies
  • Investors
  • People
  • Funding Rounds
  • Acquisitions

  • Research Reports
  • Industries
  • Locations
Mynvax-logo
Mynvax
Mynvax-logoMynvax-logo
Mynvax

Mynvax - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Private
MYNVAX PRIVATE LIMITED
Private
MYNVAX PRIVATE LIMITED
2017
2017

Founded in 2017, Mynvax operates in Health Tech industry. Initially focused on innovative vaccine research, the company has evolved to become a key player in the biotech industry. Competing with compa...

Funding stage:

Series A

Last funding:

23/05/2024

Total funding:

$6.74 Mn+

Revenue:

₹3.6 Cr+ (FY25)
Prev. FY

Investors

Employee count:

31

Last 90d

31

Last 90d

Web traffic:

417

417

Last 30d

Last 30d

Glassdoor Rating:

Mynvax: Financial Breakdown

Decoding financial health metrics of Mynvax

  • total_revenue_logo
    Total Revenue
    ₹3.6 Cr
    26%

    Prev. FY

  • total_expenses_logo
    Total Expenses
    ₹20.4 Cr
    66%

    Prev. FY

  • profit_after_tax_logo
    Profit After Tax
    ₹-16.8 Cr
    -79%

    Prev. FY

  • total_assets_logo
    Total Assets
    ₹58.8 Cr
    -13%

    Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Mynvax

No. In FY25, Mynvax reported a net loss of ₹22.6 Cr, so it was not profitable.

Mynvax's revenue grew 25.6% year-on-year, from ₹2.8 Cr in FY24 to ₹3.6 Cr in FY25.

In FY25, Mynvax posted revenue of ₹3.6 Cr (up 25.6% YoY) and a net loss of ₹22.6 Cr. Explore the full financials of Mynvax here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

MY FEEDDISCOVERRESEARCH